Wässer S, Spencker F B, Handrick W, Rieske K, Lietz R, Springer W
Klinik für Kindermedizin des Bereichs Medizin, Karl-Marx-Universität Leipzig.
Psychiatr Neurol Med Psychol (Leipz). 1987 Aug;39(8):467-74.
In a total of 223 children over one month old suffering from purulent meningitis, there was a predominance (n = 96) of meningococci over hemophilus influenzae (n = 68) and pneumococci (n = 59). Crucial to therapeutic strategy for purulent meningitis is early diagnosis, in our laboratory covering both liquor and blood cultures. Initial therapy has to take account of these three chief causal agents. We have not as yet observed any resistance to penicillin from meningococci or pneumococci, and none of the liquor-cultivated hemophilus influenzae stock has been resistant to ampicillin. In the first two years of life, initial therapy for bacterial meningitis should include ampicillin, a liberal (300-400 mg/kg KM/d) dosage continuing to be important after the onset of improvement. In view of the lack of resistance of the causal agents cultivated, we had hitherto no cell to deploy modern cephalosporins in cases of bacterial meningitis in children.
在总共223名年龄超过1个月的化脓性脑膜炎患儿中,脑膜炎球菌(n = 96)的数量超过流感嗜血杆菌(n = 68)和肺炎球菌(n = 59)。化脓性脑膜炎治疗策略的关键是早期诊断,在我们实验室中包括脑脊液和血培养。初始治疗必须考虑这三种主要病原体。我们尚未观察到脑膜炎球菌或肺炎球菌对青霉素有耐药性,且脑脊液培养的流感嗜血杆菌菌株均对氨苄西林不耐药。在生命的头两年,细菌性脑膜炎的初始治疗应包括氨苄西林,在病情改善后继续使用较大剂量(300 - 400mg/kg 每日)仍然很重要。鉴于培养出的病原体缺乏耐药性,我们此前在儿童细菌性脑膜炎病例中没有使用现代头孢菌素的必要。